THE LATEST FROM US

News archive

Strong and profitable growth continued in 2017

19.4.2018 Contract research organization StatFinn – EPID Research reports record growth in 2017. The financial statement shows total sales of € 7,2 million (2016: 4,7 million) with a growth rate of 53,7 percent (49,2). Earnings before taxes grew to € 1,1 million (0,7). “I am extremely pleas...

We presented three posters at ICPE Montreal

30.08.2017 – We presented three posters at ICPE Montreal, the 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management. The conference was held in Montreal August 26 – August 30, 2017. We presented the following posters: Spotlight poster: Adjusting for uno...

Attendance at ICPE 2017 in Montreal, Canada

26.6.2017 – We are proud to sponsor 33rd ICPE, International Conference on Pharmacoepidemiology & Therapeutic Risk Management, that will be held in Montreal, Canada this year. We look forward to meeting you! We will have an exhibition booth there for you to find us easily and to give you m...
Are you interested in learning more about how our RWE solutions can help you in your drug development and surveillance? Our team of experts is eager to discuss your specific needs. To learn more, please contact us at office@epidresearch.com.